A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals. . . . → Read More: Venture Capital Group to Boost Climate Actions
|
|||||
A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals. . . . → Read More: Venture Capital Group to Boost Climate Actions A venture capital company supporting developers of digital technologies in health care says it raised $460 million to invest in early-stage digital health businesses. . . . → Read More: New Funds to Invest in Digital Health Start-Ups A maker of consumer dairy products and biotechnology food start-up are partnering on plant-based cheeses they say are indistinguishable from today’s dairy cheese. . . . → Read More: Biotech, Dairy Company Collaborate on Plant-Based Cheese A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds. . . . → Read More: Cancer Cell Therapy Biotech Launches, Raises $10M While venture investment dollars worldwide edged higher in the first three months of 2023, the number of deals continued to slide from the previous quarter. . . . → Read More: Infographic – Q1 2023 Venture Funds Hunker Down A venture capital company specializing in early-stage investments in life science, health, and technology start-ups announced a new $850 million fund. . . . → Read More: Health, Tech Venture Investor Adds $850M Fund A new company creating biomaterials for agriculture and consumer products from large seaweed blooms is adding $5 million in its first venture funding round. . . . → Read More: Seaweed Biomaterials Start-Up Gains $5M in Early Funds Since the beginning of 2023, NBI is down more than one percent, despite showing signs of life earlier in the year. . . . → Read More: Infographic – Biotech Index Down in Q1 2023 A developer of engineered immune cells to treat cancer and immune deficiencies is raising €17.5 million ($US 19.1 million) in equity and grant funding from an EU agency. . . . → Read More: T-Cell Biotech Gains €17.5M in Grant, Equity Funds As our infographic indicates, generative A.I. can be applied in a range of industries, particularly in design and discovery functions. . . . → Read More: Infographic – Six Generative A.I. Applications |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |